Gut expression of CD71 and co-localisation with Dec-1 associated with high levels of serum SIgA and disease activity in SpA

Gut expression of CD71 and co-localisation with Dec-1 associated with high levels of serum SIgA and disease activity in SpA

Abstract Spondyloarthritis (SpA) correlates with elevated serum secretory-IgA (sSIgA). Retrotranscytosis, mediated by CD71 and Dectin-1, is linked to high sSIgA levels. This research investigated retrotranscytosis in the gut of SpA patients and its relationship with sSIgA, ileocolonoscopic findings,...

Full description

Saved in:
Bibliographic Details
Main Authors: Juliette De Ávila, Alejandro Ramos-Casallas, Myriam Lucia Velandia-Romero, Sandra Janneth Perdomo-Lara, Diana Acero-Molina, Cristian Florez-Sarmiento, Viviana Parra-Izquierdo, Jaime E. Castellanos, Lorena Chila-Moreno, Wilson Bautista-Molano, Adriana Beltran-Ostos, Diego Alejandro Jaimes, Juan Manuel Bello-Gualtero, Cesar Pacheco-Tena, Philippe Chalem, Consuelo Romero-Sánchez
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Spondyloarthritis
Subclinical gut involvement
Serum secretory IgA
Retrotranscytosis
Transferrin receptor (CD71)
Dectin-1
Online Access:https://doi.org/10.1038/s41598-025-03532-4
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Spondyloarthritis (SpA) correlates with elevated serum secretory-IgA (sSIgA). Retrotranscytosis, mediated by CD71 and Dectin-1, is linked to high sSIgA levels. This research investigated retrotranscytosis in the gut of SpA patients and its relationship with sSIgA, ileocolonoscopic findings, and activity indices. A cohort of 82 was derived from 180 patients based on selection criteria; 41 consented to DCE colonoscopy assessment. Measurements included CD71, Dec-1, sSIgA, and disease scores. Samples exhibiting apical CD71, Dec-1, or both were analysed for receptor/SIgA interactions. Apical CD71 and Dec-1 were predominantly found in the ileum. Multivariate analyses indicated CD71’s association with heightened sSIgA (p = 0.05) and ASDAS-CRP (p = 0.036; OR 1.71; 95% CI 1.00–3.11), Dec-1’s correlation with ileal inflammation (p = 0.05; OR 3.06; 95% CI 1.00–10.01), and the CD71/Dec-1 relationship with ileal villi atrophy (p = 0.038; OR 4.24; 95% CI 1.00–18.88). Microscopic evaluations demonstrated interactions between CD71/SIgA but not between CD71/Dec-1 or Dec/SIgA. The localised expression of CD71 and its co-localisation with Dec-1 may contribute to systemic increases in serum SIgA and activity scores in SpA patients. The findings suggest that sSIgA levels may serve as a non-invasive biomarker for gastrointestinal involvement in SpA and that retrotranscytosis could be a key mechanism in the gut-joint axis of SpA.
ISSN:2045-2322

Similar Items